Cargando…
Cardioprotection with halogenated gases: how does it occur?
Numerous studies have studied the effect of halogenated agents on the myocardium, highlighting the beneficial cardiac effect of the pharmacological mechanism (preconditioning and postconditioning) when employed before and after ischemia in patients with ischemic heart disease. Anesthetic preconditio...
Autores principales: | Guerrero-Orriach, Jose Luis, Escalona Belmonte, Juan Jose, Ramirez Fernandez, Alicia, Ramirez Aliaga, Marta, Rubio Navarro, Manuel, Cruz Mañas, Jose |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358986/ https://www.ncbi.nlm.nih.gov/pubmed/28352158 http://dx.doi.org/10.2147/DDDT.S127916 |
Ejemplares similares
-
Beneficial Effects of Halogenated Anesthetics in Cardiomyocytes: The Role of Mitochondria
por: Guerrero-Orriach, José Luis, et al.
Publicado: (2023) -
Preservation of renal function in cardiac surgery patients with low cardiac output syndrome: levosimendan vs beta agonists
por: Guerrero Orriach, Jose Luis, et al.
Publicado: (2019) -
Heart Failure after Cardiac Surgery: The Role of Halogenated Agents, Myocardial Conditioning and Oxidative Stress
por: Guerrero-Orriach, José Luis, et al.
Publicado: (2022) -
Renal and Neurologic Benefit of Levosimendan vs Dobutamine in Patients With Low Cardiac Output Syndrome After Cardiac Surgery: Clinical Trial FIM-BGC-2014-01
por: Guerrero-Orriach, Jose L., et al.
Publicado: (2020) -
Identification of miRNAs as Biomarkers of Cardiac Protection in Non-Genetically Modified Primary Human Cardiomyocytes Exposed to Halogenated Hypnotics in an In Vitro Model of Transfection and Ischemia/Reperfusion: A New Model in Translational Anesthesia
por: Carmona-Luque, Maria Dolores, et al.
Publicado: (2022)